• Canbud’s (CBDX) subsidiary Empathy Plant Co. has launched a woman’s daily vegan multivitamin
  • This vitamin is a unique Vegan Women’s product with 100 per cent compostable packaging
  • The multivitamin is slated to work synergistically with Empathy Plant Co’s. Green Energy and Complete Plant Protein products. The timing of the market release will be announced once production timelines are finalized
  • Canbud Distribution Corporation (CBDX) is up 6.06 per cent and is trading at C$0.18 at 3:28 pm ET

Canbud Distribution Corporation (CBDX) has completed the full development of its vegan multivitamin formula exclusively for women.

It is a unique Vegan Women’s Multi-Vitamin with 100 per cent compostable packaging.

This formula was developed to provide the market with a daily female specific multivitamin offering in 100 per cent compostable packaging.

The multivitamin will work synergistically with Empathy Plant Co’s. Green Energy and Complete Plant Protein products and will be sold as a plant-based health system.

It will be available in vegetable capsules and will provide benefits such as, but not limited to; promoting overall health, supporting hormone balance, increased energy, bone heath, eye health, and help support muscle function.

Canbud’s CEO, Steve Singh, comments,

“We continue to add products that support our health and wellness theme.”

“As we near commercialization I’m very excited to see our innovation pipeline strengthen and believe it will give us a great competitive advantage in a highly coveted consumer demographic,” added Singh.

The time of market release will be announced at a further date once production timelines are finalized.

Canbud Distribution Corporation is a science and technology health and wellness company that encompasses plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals.

Canbud Distribution Corporation (CBDX) is up 6.06 per cent and is trading at C$0.18 at 3:28 pm ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.